±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 489  |  »Ø¸´: 1
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴

bxzc123

½ð³æ (ÕýʽдÊÖ)

[ÇóÖú] Çó°ïæ·­Ò룬лл

The ultimate objective of this project is to discover new and structurally diverse hybrid isoprenoid (HI) antibiotics from marine actinomycetes.
The research focuses on an unusual group of marine actinomycetes that were discovered in the PIs laboratory and have tentatively been called
MAR4. For reasons that are not yet entirely clear, MAR4 strains have proven to be a rich source of HI secondary metabolites, which are generally
rare among bacteria. This proposal takes a unique approach that couples creative culturing techniques and poorly studied environmental
resources with molecular approaches to rapidly identify strains capable of producing HI secondary metabolites. These strains then become the
focus of detailed structure elucidation and biosynthetic studies that will reveal the mechanisms by which the compounds are assembled. The
enzymes discovered as part of these studies subsequently have the potential to be used as biochemical tools to create additional structural
diversity. The proposed studies target the discovery of a wide range of HI secondary metabolites including compounds with N and C-prenylation,
prenylated pyroles, phenazines, and peptides. The results may include the discovery of diverse new chemical structures within the broad HI class.
Major objectives include detailed phylogenetic analyses of MAR4 strains, which will expand our understanding of the diversity of bacteria that
produce HIs. A related objective is the biochemical characterization of gene clusters associated with HI biosynthesis and the cloning of specificenzymes for use as biochemical tools.
The project goals remained the same during this reporting period. These include an assessment of the diversity of MAR4 marine actinomyetes in
ocean sediments collected off the coast of California using both culture and culture independent methods. Goals include the collection of new
sediment samples and attempts to draw correlations between the abundance of MAR4 strains and environmental parameters. Additional goals
include the identification of hybrid isoprenoid (HI) secondary metabolites produced by MAR4 strains and analyses of the relationships between
MAR4 phylotype and the suite of secondary metabolites produced. We continue to work on pathways associated with HI biosynthesis, with a
focus on strain CNH-189, which produces the unusual merochlorin class of compounds.

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ľľĿС³æ

гæ (³õÈëÎÄ̳)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
RXMCDM: ½ð±Ò+1, ¶àлӦÖú 2014-10-12 12:00:25
bxzc123: ½ð±Ò+35, ·­ÒëEPI+1, ¡ï¡ï¡ïºÜÓаïÖú, лл 2014-10-12 19:30:02
bxzc123(RXMCDM´ú·¢): ½ð±Ò+15 2014-10-13 20:14:47
Õâ¸öÏîÄ¿µÄ×îÖÕÄ¿±êÊÇ´Óº£Ñó·ÅÏß¾úÖз¢ÏÖеĺͽṹ¶àÑù»¯µÄ»ìºÏÀàÒìÎì¶þÏ©¡£ÕâÏîÑо¿µÄ¶ÔÏóÊÇÒ»ÖÖÌØÊâµÄº£Ñó·ÅÏß¾ú£¬ËüÊÇÓÉPIsʵÑéÊÒ·¢Ïֵģ¬Ôݶ¨È¡ÃûΪMAR4£¬Ö÷ÒªÔ­ÒòÊÇĿǰ»¹Ã»ÓÐÍêȫŪÇå³þ£¬MAR4ϵ±»Ö¤Ã÷º¬ÓзḻµÄHI´ÎÉú´úл²úÎÕâÔÚÒ»°ãµÄϸ¾úÖÐʱºÜº±¼ûµÄ£¬Õâ¸ö·½°¸µÄÌØ±ðÖ®´¦ÔÚÓÚ£¬¼æ¾ß´´ÔìÐеÄÅàÑø¼¼Êõ£¬ÒÔ¼°ÔÚ¶ñÁÓµÄÑо¿»·¾³ÏÂÄܹ»ÀûÓ÷Ö×Ó·ÖÎö·½·¨Ñ¸ËٵķÖÎö³öÆäÖÆÔì»ìºÏÀàÒìÎì¶þÏ©¶þ¼¶²úÎïµÄÄÜÁ¦£¬ÕâÑù¾ÍÄܶÔMAR4ϵ½øÐоßÌå½á¹¹·ÖÎöºÍÉúÎïºÏ³ÉÑо¿£¬½ø¶øÍ¨¹ýÕâЩ½á¹û¶ÔÆä½øÐкϳɡ£Ëæºó£¬ÔÚÕâ¸öÑо¿Öз¢ÏֵĸºÜÓÐ×÷ΪÉú»¯¹¤¾ß´´ÔìÆäËü½á¹¹¸´ÔÓÎïÖʵÄDZÁ¦¡£Õâ¸öÏîÄ¿µÄÑо¿Ä¿µÄÊÇ·¢ÏÖÒ»ÖÖ°üº¬NºÍc-ÒìÎìÏ©¡¢ÒìÎìßÁ¿©¡¢·Ôຠ¡¢ëĵķºHI¶þ¼¶²úÎ½á¹ûÒ²Ðí»á°üº¬HI¼Ò×åÖеĽṹ¶àÑù»¯µÄÐÂÎïÖÊ¡£Ö÷ҪĿ±ê»¹°üÀ¨¶ÔMAR4ϵµÄ¾ßÌå½ø»¯·ÖÎö£¬ÕâÄܹ»°ïÖúÎÒÃÇÁ˽â¸ü¶àÄܹ»²úÉúHIsµÄ¶àÑù»¯Ï¸¾ú£¬Ïà¹Ø½á¹ûÊÇÓëHIsºÏ³ÉÏà¹Ø»ùÒòµÄÉú»¯±íÕ÷ºÍÒÔ¼°¿Ë¡³öÕâÖÖÄܹ»×÷ΪÉú»¯¹¤¾ßµÄø£¬Õâ¸öÏîÄ¿»¹ÔÚÑо¿½×¶ÎµÄÊÇ£¬ÀûÓöԴӼÓÀû¸£ÄáÑǺ£°¶³Á»ýÎïÖÐÊÕ¼¯µÄMAR4·ÅÏß¾ú½øÐÐÅàÑø»òÕßµ¥¶ÀÅàÑøµÄ·½Ê½¶ÔÆä¶àÑùÐÔ½øÐÐÆÀ¹À£¬Ä¿±ê°üÀ¨ÊÕ¼¯ÐµÄÄàɳÑù±¾£¬ÒÔÊÔͼÕÒ³öMAR4ϵ·á¸»³Ì¶ÈÓë»·¾³²ÎÊýµÄ¹ØÏµ¡£ÁíÍ⻹°üÀ¨¼ø¶¨MAR4ϵËù²úÉúµÄHI´ÎÉú´úлÎïºÍ·ÖÎöMAR4·ÅÏß¾úºÍÉú²ú´ÎÉú´úл²úÎïµÄ¹¤¾ßµÄ¹ØÏµ¡£ÎÒÃǽ«¼ÌÐøÑо¿HIsºÏ³ÉµÄÏà¹Ø·½·¨£¬Ö÷Òª¼¯ÖÐÔÚ¶ÔCNH-189ϵµÄÑо¿£¬ËüÄܹ»²úÉúÒ»ÖÖÌØÊâµÄø¡£
2Â¥2014-10-12 10:46:29
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ bxzc123 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ²ÄÁÏ334Çóµ÷¼Á +18 Eecho# 2026-04-03 18/900 2026-04-06 00:56 by fmesaito
[¿¼ÑÐ] 272·ÖÇóµ÷¼Á +4 wangyile2233 2026-04-02 4/200 2026-04-05 22:21 by 286640313
[¿¼ÑÐ] 285Çóµ÷¼Á +4 ¶ñ·¨´ó¶þµÄÆøÎ¶ß 2026-04-05 5/250 2026-04-05 20:32 by 286640313
[¿¼ÑÐ] 367Çóµ÷¼Á +3 л28 2026-03-30 3/150 2026-04-05 13:27 by huangmoli
[¿¼ÑÐ] 298·Ö 070300Çóµ÷¼Á +15 zwen03 2026-04-02 15/750 2026-04-05 12:52 by Hdyxbekcb
[¿¼ÑÐ] 081700ѧ˶£¬323·Ö£¬Ò»Ö¾Ô¸Öйúº£Ñó´óѧÇóµ÷¼ÁѧУ +16 ÅûÐÇºÓ 2026-04-04 16/800 2026-04-05 11:27 by Öí»á·É
[¿¼ÑÐ] 313Çóµ÷¼Á +3 º£ÈÕº£ÈÕ 2026-04-04 3/150 2026-04-05 07:48 by 544594351
[¿¼ÑÐ] 283Çóµ÷¼Á +3 jiouuu 2026-04-03 4/200 2026-04-03 13:28 by jiouuu
[¿¼ÑÐ] 266·Ö£¬Ò»Ö¾Ô¸µçÆø¹¤³Ì£¬±¾¿Æ²ÄÁÏ£¬Çó²ÄÁÏרҵµ÷¼Á +9 ÍÛºôºßºôºß 2026-04-02 9/450 2026-04-03 12:05 by 1753564080
[¿¼ÑÐ] ³õÊԳɼ¨337ÕÒµ÷¼Á +3 ??? ?. ? 2026-04-03 3/150 2026-04-03 11:43 by ÍÁľ˶ʿÕÐÉú
[¿¼ÑÐ] Çóµ÷¼Á +3 ÐÄÏëÊÂ³É¿É 2026-04-03 3/150 2026-04-03 11:22 by wangjy2002
[¿¼ÑÐ] ±§Ç¸ +5 ÌïºéÓÐ 2026-03-30 5/250 2026-04-03 10:24 by linyelide
[¿¼ÑÐ] Ò»Ö¾Ô¸¸´µ©²ÄÁÏ£¬Ó¢Ò»×¨Ë¶£¬×Ü·Ö357µ÷¼Á +4 1050389037 2026-04-02 5/250 2026-04-02 21:40 by dongzh2009
[¿¼ÑÐ] Çóµ÷¼Á +7 Aniyaio 2026-04-02 7/350 2026-04-02 16:42 by zzsw+
[¿¼²©] ²ÄÁϹ¤³Ìרҵ˶ʿÉ격 +3 ÷ëÕýÓî 2026-03-30 3/150 2026-04-02 15:04 by greychen00
[¿¼ÑÐ] 285Çóµ÷¼Á +11 AZMK 2026-04-01 11/550 2026-04-01 22:40 by peike
[¿¼ÑÐ] 350Çóµ÷¼Á +7 °¢¼Ñ¡« 2026-03-31 7/350 2026-04-01 16:12 by yanflower7133
[¿¼ÑÐ] ʡ˫һÁ÷ÖØµãÒ»±¾´óѧÕÐÊÕµ÷¼Á +4 wwwwffffff 2026-03-31 7/350 2026-04-01 15:23 by wwwwffffff
[˶²©¼ÒÔ°] ¿¼Ñе÷¼Á +5 ÂæÍÕÄÐÈË 2026-04-01 5/250 2026-04-01 14:28 by syjjj0321
[¿¼ÑÐ] 08¹¤¿Æ£¬295£¬½ÓÊÜ¿çרҵµ÷¼Á +6 lmnlzy 2026-03-31 6/300 2026-04-01 11:02 by ÄæË®³Ë·ç
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û